Stories about breast cancer that can inspire and inform

Blog  |  Newsroom

End the Wait and Pass the Metastatic Breast Cancer Access to Care Act

The Metastatic Breast Cancer Access (MBC) to Care Act is federal legislation that would immediately end the wait times for someone living with MBC to receive Social Security Disability Insurance and Medicare, benefits that they rely on to live. MBC is an aggressive form of cancer that has spread beyond the breast to nearby organs […]

VIPink: Leaders Fundraising to End Breast Cancer

For community leaders motivated to help end breast cancer, Susan G. Komen’s ambassador fundraising programs offer dedicated supporters a chance to engage with their networks to fundraise in support of Komen. This story highlights the journeys of three of Komen’s dedicated supporters who inspired others to give back and make a meaningful impact in the fight to end breast cancer.

Shining a Spotlight on the Promise of Exercise in the Management of MBC 

Research has shown that exercise can improve overall survival, treatment tolerability and quality of life for women with early-stage breast cancer. But what about women who are living with metastatic breast cancer (MBC)? Through a clinical trial, researchers are exploring whether the addition of exercise to standard treatment could hold promise for women living with […]

Natalie’s Story: Pieces of Me

Natalie was diagnosed with triple negative breast cancer in 2023. “This journey has changed me in ways I never imagined. It has taken pieces of me, but it has also revealed a strength I didn’t know I had,” she said. “I’m a mother, a survivor, a fighter, a mentor and someone who has learned to live fully, embracing both the visible and invisible scars that cancer has left behind.”

Breast Cancer Breakthroughs Episode 11 – Changing the Game with New Hormone Therapies for ER-Positive Breast Cancer 

For the past 20 years, people with early estrogen receptor-positive (ER+) breast cancer have received a standard treatment, including hormone therapies like aromatase inhibitors or tamoxifen. While these patients generally have good outcomes after this treatment, they are still at risk for recurrence. As researchers seek more targeted and effective treatments for people with early […]